CClinicalTrials.gg
CompletedNCT00431327Updated May 24, 2023

Facilitators to Keeping Colonoscopy Appointments

An Early Phase 1 interventional study of Peer coach phone call in Healthy, sponsored by University of Pennsylvania. Completed at 1 site in United States. Open to participants aged 50 Years and older. Per ClinicalTrials.gov, last updated 2023-05-24.

Sponsored by University of Pennsylvania · Early Phase 1, Interventional, and Prevention

Phase
Early Phase 1
Study type
Interventional
Enrollment
140
Allocation
Randomized
Ages
50 Years and older
Sex
All
01

Study summary

To identify patients at risk for nonattendance to their first scheduled colonoscopy and to conduct a randomized trial of a theory-based, peer coach intervention on completing the scheduled colonoscopy.

Read the detailed description

The potential to reduce the morbidity and mortality from colorectal cancer, the second most common cause of cancer death in the U.S. has been compromised because only about half of eligible patients have been appropriately screened. Patients contribute to inadequate colorectal cancer screening by failing to complete ordered tests. Several studies have reported low rates of attendance to scheduled sigmoidoscopy and colonoscopy studies. Because physicians offer limited counseling when ordering these tests, approaches are needed to address patient concerns and to promote adherence to scheduled colon studies. Therefore, we conducted a trial of a theory-based telephone intervention by patient 'peer coach' who was trained to address barriers to colonoscopy attendance versus a mailed professional brochure. The support was targeted to those at greatest risk of non-attendance.

02

Conditions studied

  • Healthy

Keywords

  • patient navigator
  • peer support
  • colonoscopy
  • adherence
  • None: have to be scheduled for screening or diagnostic colonoscopy
03

In context

Lead sponsor

University of Pennsylvania is the lead sponsor of 1,635 studies on the registry; 239 are open to participants now.

Of its 154 completed or terminated interventional studies of FDA-regulated products, 104 (68%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age 50
  • No prior colonoscopy in our health system records
  • Patient in one of four primary care clinics within the University of Pennsylvania Health System
  • Attended \<75 of their primary care physicians visits within the past year

Exclusion criteria

Exclusion Criteria:

  • Colonoscopy not ordered by a primary care physician in a study clinic
  • High readiness for the procedure
  • A health care professional
  • Had a prior colonoscopy outside of our health care system
05

Study design

Phase
Early Phase 1
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
140 participants

Interventions

  • BehavioralPeer coach phone call
06

What researchers measure

Primary outcomes

  1. Attending the colonoscopy

07

Study locations

1 site
  • University of Pennsylvania
    Philadelphia, Pennsylvania 19104, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 24, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00431327
Lead sponsor
University of Pennsylvania
First posted
Feb 5, 2007
Start date
Feb 2005
Completion
Oct 2006
Last update
May 24, 2023

Study contacts

Barbara J Turner, MD
principal investigator · University of Pennsylvania
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion